Overview

Exparel Injection Effect on Postoperative Opioid Usage

Status:
Enrolling by invitation
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The question proposed by this study, is one of patient outcomes. Does intraoperative injection of Exparel decrease postoperative use of opioid pain medications in patients undergoing thyroid and parathyroid surgery? The trial seeks to assess the effect that Exparel has on postoperative pain control.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Missouri-Columbia
Treatments:
Bupivacaine
Epinephrine
Epinephryl borate
Lidocaine
Parathyroid Hormone
Racepinephrine